3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
23 24 0 1 0 0 0 0 0999 V2000
1.1156 -1.0412 -1.0723 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.5601 -1.7622 -0.2174 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.5927 1.7790 0.6032 O 0 0 0 0 0 0 0 0 0 0 0 0
2.3518 0.9308 -0.2726 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0801 -0.0918 -0.8074 C 0 0 2 0 0 0 0 0 0 0 0 0
1.3723 -0.1085 -0.0117 C 0 0 1 0 0 0 0 0 0 0 0 0
-1.0277 -0.4956 0.1529 C 0 0 2 0 0 0 0 0 0 0 0 0
0.9665 -0.3767 1.3764 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3489 -0.6180 1.5058 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1495 0.5367 0.1904 C 0 0 2 0 0 0 0 0 0 0 0 0
-2.7988 0.7003 -1.1735 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5914 0.5473 -0.2738 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0984 0.6970 -1.5180 H 0 0 0 0 0 0 0 0 0 0 0 0
1.6691 -0.4025 2.1979 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.8499 -0.8581 2.4319 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.9167 0.2414 0.9169 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.2443 -2.0040 0.4303 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.1402 1.1758 -1.9058 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.6633 1.3693 -1.0862 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.1584 -0.2504 -1.5780 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.3136 2.4313 0.6237 H 0 0 0 0 0 0 0 0 0 0 0 0
4.3902 1.2801 -0.4643 H 0 0 0 0 0 0 0 0 0 0 0 0
3.8926 -0.4975 -0.0900 H 0 0 0 0 0 0 0 0 0 0 0 0
1 5 1 0 0 0 0
1 6 1 0 0 0 0
2 7 1 0 0 0 0
2 17 1 0 0 0 0
3 10 1 0 0 0 0
3 21 1 0 0 0 0
4 6 1 0 0 0 0
4 12 2 0 0 0 0
5 6 1 0 0 0 0
5 7 1 0 0 0 0
5 13 1 0 0 0 0
6 8 1 0 0 0 0
7 9 1 0 0 0 0
7 10 1 0 0 0 0
8 9 2 0 0 0 0
8 14 1 0 0 0 0
9 15 1 0 0 0 0
10 11 1 0 0 0 0
10 16 1 0 0 0 0
11 18 1 0 0 0 0
11 19 1 0 0 0 0
11 20 1 0 0 0 0
12 22 1 0 0 0 0
12 23 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
(1S,2R,5R)-2-[(1S)-1-hydroxyethyl]-5-(methylideneamino)-6-oxabicyclo[3.1.0]hex-3-en-2-ol
4.2 InChl
InChI=1S/C8H11NO3/c1-5(10)7(11)3-4-8(9-2)6(7)12-8/h3-6,10-11H,2H2,1H3/t5-,6-,7+,8+/m0/s1
4.3 InChlKey
RYEOWDOXPQFCKX-RULNZFCNSA-N
4.4 Canonical SMILES
C[C@@H]([C@@]1(C=C[C@@]2([C@H]1O2)N=C)O)O
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病